Frankenfield Christopher James bought XLO
January 1, 2026 · Form 4 insider transaction
Frankenfield Christopher James bought 19,375 shares of Xilio Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,375
Price
N/A
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 1, 2026
Filing dateJanuary 5, 2026
Shares owned after31,796
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units ("RSUs") convert to stock on a one-for-one basis.